Clinical Trial Update: A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a fractional booster dose of GlaxoSmithKline's malaria vaccine in previously vaccinated malaria-naïve adults; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Malaria vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2020-05-15